O	0	10	Prognostic	Prognostic	JJ	B-NP
O	11	23	significance	significance	NN	I-NP
O	24	26	of	of	IN	B-PP
O	27	31	heat	heat	NN	B-NP
O	32	37	shock	shock	NN	I-NP
O	38	45	protein	protein	NN	I-NP
O	46	48	27	27	CD	I-NP
O	49	50	(	(	(	O
O	50	55	HSP27	HSP27	NN	B-NP
O	55	56	)	)	)	O
O	57	59	in	in	IN	B-PP
O	60	68	patients	patient	NNS	B-NP
O	69	73	with	with	IN	B-PP
B-Cancer	74	78	oral	oral	JJ	B-NP
I-Cancer	79	87	squamous	squamous	JJ	I-NP
I-Cancer	88	92	cell	cell	NN	I-NP
I-Cancer	93	102	carcinoma	carcinoma	NN	I-NP
O	102	103	.	.	.	O

O	105	109	Heat	Heat	NN	B-NP
O	110	115	shock	shock	NN	I-NP
O	116	124	proteins	protein	NNS	I-NP
O	125	126	(	(	(	O
O	126	130	HSPs	HSP	NNS	B-NP
O	130	131	)	)	)	O
O	132	136	have	have	VBP	B-VP
O	137	141	been	be	VBN	I-VP
O	142	149	defined	define	VBN	I-VP
O	150	152	as	as	IN	B-PP
O	153	161	proteins	protein	NNS	B-NP
O	162	169	induced	induce	VBN	B-VP
O	170	172	by	by	IN	B-PP
O	173	177	heat	heat	NN	B-NP
O	178	183	shock	shock	NN	I-NP
O	184	187	and	and	CC	O
O	188	193	other	other	JJ	B-NP
O	194	207	environmental	environmental	JJ	I-NP
O	208	211	and	and	CC	I-NP
O	212	228	pathophysiologic	pathophysiologic	JJ	I-NP
O	229	235	stress	stress	NN	I-NP
O	235	236	.	.	.	O

O	237	241	Heat	Heat	NN	B-NP
O	242	247	shock	shock	NN	I-NP
O	248	255	protein	protein	NN	I-NP
O	256	258	27	27	CD	I-NP
O	259	260	(	(	(	O
O	260	265	HSP27	HSP27	NN	B-NP
O	265	266	)	)	)	O
O	267	269	is	be	VBZ	B-VP
O	270	273	one	one	CD	B-NP
O	274	276	of	of	IN	B-PP
O	277	280	the	the	DT	B-NP
O	281	286	small	small	JJ	I-NP
O	287	291	heat	heat	NN	I-NP
O	292	297	shock	shock	NN	I-NP
O	298	306	proteins	protein	NNS	I-NP
O	306	307	.	.	.	O

O	308	313	HSP27	HSP27	NN	B-NP
O	314	316	is	be	VBZ	B-VP
O	317	327	implicated	implicate	VBN	I-VP
O	328	330	in	in	IN	B-PP
O	331	338	protein	protein	NN	B-NP
O	338	339	-	-	HYPH	B-NP
O	339	346	protein	protein	NN	I-NP
O	347	359	interactions	interaction	NNS	I-NP
O	360	364	such	such	JJ	B-PP
O	365	367	as	as	IN	I-PP
O	368	375	folding	folding	NN	B-NP
O	375	376	,	,	,	O
O	377	390	translocation	translocation	NN	B-NP
O	390	391	,	,	,	O
O	392	395	and	and	CC	O
O	396	406	prevention	prevention	NN	B-NP
O	407	409	of	of	IN	B-PP
O	410	423	inappropriate	inappropriate	JJ	B-NP
O	424	431	protein	protein	NN	I-NP
O	432	443	aggregation	aggregation	NN	I-NP
O	443	444	.	.	.	O

O	445	449	Many	Many	JJ	B-NP
O	450	452	of	of	IN	B-PP
O	453	458	their	their	PRP$	B-NP
O	459	468	functions	function	NNS	I-NP
O	469	476	suggest	suggest	VBP	B-VP
O	477	481	that	that	IN	B-SBAR
O	482	486	they	they	PRP	B-NP
O	487	491	play	play	VBP	B-VP
O	492	501	important	important	JJ	B-NP
O	502	507	roles	role	NNS	I-NP
O	508	510	in	in	IN	B-PP
B-Cancer	511	518	cancers	cancer	NNS	B-NP
O	518	519	.	.	.	O

B-Tissue	520	528	Archival	Archival	JJ	B-NP
I-Tissue	529	536	tissues	tissue	NNS	I-NP
O	537	541	from	from	IN	B-PP
O	542	544	40	40	CD	B-NP
O	545	553	patients	patient	NNS	I-NP
O	554	558	with	with	IN	B-PP
B-Cancer	559	563	oral	oral	JJ	B-NP
I-Cancer	564	572	squamous	squamous	JJ	I-NP
I-Cancer	573	577	cell	cell	NN	I-NP
I-Cancer	578	587	carcinoma	carcinoma	NN	I-NP
O	588	591	who	who	WP	B-NP
O	592	600	received	receive	VBD	B-VP
O	601	608	primary	primary	JJ	B-NP
O	609	617	surgical	surgical	JJ	I-NP
O	618	627	resection	resection	NN	I-NP
O	628	632	were	be	VBD	B-VP
O	633	641	examined	examine	VBN	I-VP
O	642	645	for	for	IN	B-PP
O	646	651	HSP27	HSP27	NN	B-NP
O	652	654	by	by	IN	B-PP
O	655	675	immunohistochemistry	immunohistochemistry	NN	B-NP
O	676	679	and	and	CC	O
O	680	690	correlated	correlate	VBD	B-VP
O	691	695	with	with	IN	B-PP
O	696	704	clinical	clinical	JJ	B-NP
O	705	710	stage	stage	NN	I-NP
O	710	711	,	,	,	O
B-Multi-tissue_structure	712	717	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	718	722	node	node	NN	I-NP
O	723	733	metastasis	metastasis	NN	I-NP
O	733	734	,	,	,	O
O	735	747	histological	histological	JJ	B-NP
O	748	753	grade	grade	NN	I-NP
O	754	757	and	and	CC	I-NP
O	758	766	survival	survival	NN	I-NP
O	767	773	period	period	NN	I-NP
O	773	774	.	.	.	O

O	775	780	HSP27	HSP27	NN	B-NP
O	781	791	expression	expression	NN	I-NP
O	792	795	was	be	VBD	B-VP
O	796	804	positive	positive	JJ	B-NP
O	805	813	staining	staining	NN	I-NP
O	814	815	(	(	(	O
O	815	816	+	+	SYM	B-NP
O	816	817	)	)	)	O
O	818	820	in	in	IN	B-PP
O	821	823	20	20	CD	B-NP
O	824	825	(	(	(	O
O	825	827	50	50	CD	B-NP
O	827	828	%	%	NN	I-NP
O	828	829	)	)	)	O
O	829	830	,	,	,	O
O	831	835	weak	weak	JJ	B-NP
O	836	838	or	or	CC	I-NP
O	839	847	negative	negative	JJ	I-NP
O	848	856	staining	staining	NN	I-NP
O	857	858	(	(	(	O
O	858	859	-	-	SYM	B-NP
O	859	860	)	)	)	O
O	861	863	in	in	IN	B-PP
O	864	866	20	20	CD	B-NP
O	867	868	(	(	(	O
O	868	870	50	50	CD	B-NP
O	870	871	%	%	NN	I-NP
O	871	872	)	)	)	O
O	873	875	of	of	IN	B-PP
O	876	881	total	total	JJ	B-NP
O	882	884	40	40	CD	I-NP
O	885	890	cases	case	NNS	I-NP
O	890	891	.	.	.	O

O	892	897	There	There	EX	B-NP
O	898	901	was	be	VBD	B-VP
O	902	904	no	no	DT	B-NP
O	905	916	correlation	correlation	NN	I-NP
O	917	924	between	between	IN	B-PP
O	925	930	HSP27	HSP27	NN	B-NP
O	931	941	expression	expression	NN	I-NP
O	942	945	and	and	CC	O
O	946	954	clinical	clinical	JJ	B-NP
O	955	960	stage	stage	NN	I-NP
O	960	961	,	,	,	O
B-Multi-tissue_structure	962	967	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	968	972	node	node	NN	I-NP
O	973	983	metastasis	metastasis	NN	I-NP
O	984	987	and	and	CC	O
O	988	1000	histological	histological	JJ	B-NP
O	1001	1006	grade	grade	NN	I-NP
O	1006	1007	.	.	.	O

O	1008	1015	However	However	RB	B-ADVP
O	1015	1016	,	,	,	O
O	1017	1021	when	when	WRB	B-ADVP
O	1022	1030	compared	compare	VBN	B-PP
O	1031	1035	with	with	IN	B-PP
O	1036	1055	clinicopathological	clinicopathological	JJ	B-NP
O	1056	1064	features	feature	NNS	I-NP
O	1064	1065	,	,	,	O
O	1066	1069	the	the	DT	B-NP
O	1070	1080	expression	expression	NN	I-NP
O	1081	1083	of	of	IN	B-PP
O	1084	1089	HSP27	HSP27	NN	B-NP
O	1090	1100	correlated	correlate	VBD	B-VP
O	1101	1110	inversely	inversely	RB	B-ADVP
O	1111	1115	with	with	IN	B-PP
O	1116	1124	survival	survival	NN	B-NP
O	1125	1131	period	period	NN	I-NP
O	1131	1132	.	.	.	O

O	1133	1137	This	This	DT	B-NP
O	1138	1143	study	study	NN	I-NP
O	1144	1152	suggests	suggest	VBZ	B-VP
O	1153	1157	that	that	IN	B-SBAR
O	1158	1161	the	the	DT	B-NP
O	1162	1172	expression	expression	NN	I-NP
O	1173	1175	of	of	IN	B-PP
O	1176	1181	HSP27	HSP27	NN	B-NP
O	1182	1184	is	be	VBZ	B-VP
O	1185	1195	frequently	frequently	RB	I-VP
O	1196	1204	promoted	promote	VBN	I-VP
O	1205	1207	in	in	IN	B-PP
O	1208	1216	patients	patient	NNS	B-NP
O	1217	1221	with	with	IN	B-PP
B-Cancer	1222	1226	oral	oral	JJ	B-NP
I-Cancer	1227	1235	squamous	squamous	JJ	I-NP
I-Cancer	1236	1240	cell	cell	NN	I-NP
I-Cancer	1241	1250	carcinoma	carcinoma	NN	I-NP
O	1251	1254	and	and	CC	O
O	1255	1261	should	should	MD	B-VP
O	1262	1264	be	be	VB	I-VP
O	1265	1275	considered	consider	VBN	I-VP
O	1276	1278	an	an	DT	B-NP
O	1279	1290	independent	independent	JJ	I-NP
O	1291	1301	prognostic	prognostic	JJ	I-NP
O	1302	1308	factor	factor	NN	I-NP
O	1309	1311	of	of	IN	B-PP
B-Cancer	1312	1316	oral	oral	JJ	B-NP
I-Cancer	1317	1325	squamous	squamous	JJ	I-NP
I-Cancer	1326	1330	cell	cell	NN	I-NP
I-Cancer	1331	1340	carcinoma	carcinoma	NN	I-NP
O	1341	1349	patients	patient	NNS	I-NP
O	1349	1350	.	.	.	O

